drugset

drugset / Trial / NCT02972528

The Use of Allogenic Platelet Rich Plasma for the Treatment of Diabetic Foot Ulcer

NCT02972528 ↗

Phase 1/2 Unknown 30 enrolled Hanan Jafar

RandomizedParallel-groupDouble-blindTreatment

Summary

Allogenic defibrinated platelet rich plasma lysate will be injected in patients diagnosed with Diabetic Foot Ulcer (DFU).

Timeline

Start: 2018-02-03
Primary completion: 2020-02
Completion: 2020-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Platelet Lysate	Unknown	5 ml	Other

Indications